摘要:
The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain.
摘要:
The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xExxxLL (SEQ ID NO: 112) at the C-terminus, wherein x is any amino acid.
摘要翻译:本发明涉及包含E型肉毒杆菌毒素修饰轻链的毒素,其中所述修饰的轻链包含在N末端的氨基酸序列PFVNKQFN(SEQ ID NO:120)和氨基酸序列xExxxLL(SEQ ID NO: NO:112),其中x是任何氨基酸。
摘要:
The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain.
摘要:
The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain.
摘要:
The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xDxxxLL (SEQ ID NO: 111) at the C-terminus, wherein x is any amino acid.
摘要翻译:本发明涉及包含E型肉毒杆菌毒素的修饰轻链的毒素,其中所述修饰的轻链在N-末端包含氨基酸序列PFVNKQFN(SEQ ID NO:120)和氨基酸序列xDxxxLL(SEQ ID NO: NO:111),其中x是任何氨基酸。
摘要:
The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xExxxLL (SEQ ID NO: 112) at the C-terminus, wherein x is any amino acid.
摘要翻译:本发明涉及包含E型肉毒杆菌毒素修饰轻链的毒素,其中所述修饰的轻链包含在N末端的氨基酸序列PFVNKQFN(SEQ ID NO:120)和氨基酸序列xExxxLL(SEQ ID NO: NO:112),其中x是任何氨基酸。
摘要:
The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xExxxLL (SEQ ID NO: 112) at the C-terminus, wherein x is any amino acid.
摘要翻译:本发明涉及包含E型肉毒杆菌毒素修饰轻链的毒素,其中所述修饰的轻链包含在N末端的氨基酸序列PFVNKQFN(SEQ ID NO:120)和氨基酸序列xExxxLL(SEQ ID NO: NO:112),其中x是任何氨基酸。
摘要:
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
摘要:
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
摘要:
The present specification discloses SNAP-25 compositions, methods of making α-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, α-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, methods of detecting BoNT/A activity, and methods of detecting neutralizing α-BoNT/A antibodies.